S&P 500   3,251.17 (-2.06%)
DOW   26,902.19 (-2.73%)
QQQ   265.20 (-0.63%)
AAPL   107.53 (+0.65%)
MSFT   200.51 (+0.06%)
FB   249.56 (-1.18%)
GOOGL   1,431.50 (-1.35%)
AMZN   2,920.73 (-1.16%)
NVDA   494.60 (+1.44%)
TSLA   447.16 (+1.13%)
BABA   271.69 (-0.26%)
CGC   15.71 (-3.97%)
GE   6.28 (-8.72%)
MU   49.24 (-2.96%)
AMD   77.30 (+3.16%)
T   28.41 (-1.80%)
F   6.88 (-4.84%)
ACB   6.33 (-3.06%)
GILD   63.76 (-1.98%)
NFLX   480.81 (+2.31%)
DIS   125.05 (-2.78%)
BAC   24.23 (-3.89%)
BA   157.94 (-1.99%)
S&P 500   3,251.17 (-2.06%)
DOW   26,902.19 (-2.73%)
QQQ   265.20 (-0.63%)
AAPL   107.53 (+0.65%)
MSFT   200.51 (+0.06%)
FB   249.56 (-1.18%)
GOOGL   1,431.50 (-1.35%)
AMZN   2,920.73 (-1.16%)
NVDA   494.60 (+1.44%)
TSLA   447.16 (+1.13%)
BABA   271.69 (-0.26%)
CGC   15.71 (-3.97%)
GE   6.28 (-8.72%)
MU   49.24 (-2.96%)
AMD   77.30 (+3.16%)
T   28.41 (-1.80%)
F   6.88 (-4.84%)
ACB   6.33 (-3.06%)
GILD   63.76 (-1.98%)
NFLX   480.81 (+2.31%)
DIS   125.05 (-2.78%)
BAC   24.23 (-3.89%)
BA   157.94 (-1.99%)
S&P 500   3,251.17 (-2.06%)
DOW   26,902.19 (-2.73%)
QQQ   265.20 (-0.63%)
AAPL   107.53 (+0.65%)
MSFT   200.51 (+0.06%)
FB   249.56 (-1.18%)
GOOGL   1,431.50 (-1.35%)
AMZN   2,920.73 (-1.16%)
NVDA   494.60 (+1.44%)
TSLA   447.16 (+1.13%)
BABA   271.69 (-0.26%)
CGC   15.71 (-3.97%)
GE   6.28 (-8.72%)
MU   49.24 (-2.96%)
AMD   77.30 (+3.16%)
T   28.41 (-1.80%)
F   6.88 (-4.84%)
ACB   6.33 (-3.06%)
GILD   63.76 (-1.98%)
NFLX   480.81 (+2.31%)
DIS   125.05 (-2.78%)
BAC   24.23 (-3.89%)
BA   157.94 (-1.99%)
S&P 500   3,251.17 (-2.06%)
DOW   26,902.19 (-2.73%)
QQQ   265.20 (-0.63%)
AAPL   107.53 (+0.65%)
MSFT   200.51 (+0.06%)
FB   249.56 (-1.18%)
GOOGL   1,431.50 (-1.35%)
AMZN   2,920.73 (-1.16%)
NVDA   494.60 (+1.44%)
TSLA   447.16 (+1.13%)
BABA   271.69 (-0.26%)
CGC   15.71 (-3.97%)
GE   6.28 (-8.72%)
MU   49.24 (-2.96%)
AMD   77.30 (+3.16%)
T   28.41 (-1.80%)
F   6.88 (-4.84%)
ACB   6.33 (-3.06%)
GILD   63.76 (-1.98%)
NFLX   480.81 (+2.31%)
DIS   125.05 (-2.78%)
BAC   24.23 (-3.89%)
BA   157.94 (-1.99%)
Log in
NYSE:RAD

Rite Aid Stock Forecast, Price & News

$13.54
+0.10 (+0.74 %)
(As of 09/21/2020 01:32 PM ET)
Add
Compare
Today's Range
$12.97
Now: $13.54
$13.65
50-Day Range
$11.75
MA: $13.84
$15.63
52-Week Range
$6.59
Now: $13.54
$23.88
Volume72,824 shs
Average Volume4.63 million shs
Market Capitalization$739.87 million
P/E RatioN/A
Dividend YieldN/A
Beta0.76
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and an assortment of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and provides preventative services, such as screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order and specialty pharmacy services, as well as drug benefits under the federal government's Medicare Part D program. As of April 11, 2019, the company operated 2,469 stores in 18 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Read More
Rite Aid logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.68 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP76775410
Phone717-761-2633

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.93 billion
Cash Flow$7.05 per share
Book Value$12.31 per share

Profitability

Net Income$-452,170,000.00

Miscellaneous

Employees48,000
Market Cap$739.87 million
Next Earnings Date9/24/2020 (Confirmed)
OptionableOptionable
$13.54
+0.10 (+0.74 %)
(As of 09/21/2020 01:32 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rite Aid (NYSE:RAD) Frequently Asked Questions

How has Rite Aid's stock been impacted by COVID-19 (Coronavirus)?

Rite Aid's stock was trading at $14.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RAD shares have decreased by 4.2% and is now trading at $13.54.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Rite Aid?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Rite Aid
.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020.
View our earnings forecast for Rite Aid
.

How can I listen to Rite Aid's earnings call?

Rite Aid will be holding an earnings conference call on Thursday, September 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, June, 25th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.34. The company had revenue of $6.03 billion for the quarter, compared to analysts' expectations of $5.61 billion. Rite Aid had a negative net margin of 1.84% and a positive return on equity of 1.66%. The business's revenue was up 12.2% on a year-over-year basis.
View Rite Aid's earnings history
.

When did Rite Aid's stock split? How did Rite Aid's stock split work?

Shares of Rite Aid reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of Rite Aid stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for RAD?

3 equities research analysts have issued 12 month price targets for Rite Aid's shares. Their forecasts range from $17.00 to $18.00. On average, they anticipate Rite Aid's stock price to reach $17.50 in the next year. This suggests a possible upside of 29.2% from the stock's current price.
View analysts' price targets for Rite Aid
.

Who are some of Rite Aid's key competitors?

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Celgene (CELG), Akorn (AKRX), Bank of America (BAC), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and AT&T (T).

Who are Rite Aid's key executives?

Rite Aid's management team includes the following people:
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP & Chief Pharmacy Officer (Age 50)
  • Ms. Heyward Rutledge Donigan B.A., Pres CEO & Director (Age 59)
  • Mr. Matthew Schroeder, CFO & Exec. VP (Age 50)
  • Mr. James J. Peters, Chief Operating Officer (Age 48)
  • Mr. Brian Hoover, Chief Accounting Officer (Age 55)

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.62%), Alberta Investment Management Corp (1.90%), Charles Schwab Investment Management Inc. (1.41%), Bank of New York Mellon Corp (0.76%), Jacobs Levy Equity Management Inc. (0.76%) and Nuveen Asset Management LLC (0.72%).
View institutional ownership trends for Rite Aid
.

Which major investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Charles Schwab Investment Management Inc., SeaCrest Wealth Management LLC, Vanguard Group Inc., California State Teachers Retirement System, Advisor Group Holdings Inc., World Asset Management Inc, and Mackay Shields LLC.
View insider buying and selling activity for Rite Aid
.

Which major investors are buying Rite Aid stock?

RAD stock was purchased by a variety of institutional investors in the last quarter, including Jacobs Levy Equity Management Inc., Bridgeway Capital Management Inc., Bank of America Corp DE, Cubist Systematic Strategies LLC, UBS Group AG, Engineers Gate Manager LP, AQR Capital Management LLC, and Nuveen Asset Management LLC.
View insider buying and selling activity for Rite Aid
.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $13.54.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $739.87 million and generates $21.93 billion in revenue each year. The company earns $-452,170,000.00 in net income (profit) each year or $0.15 on an earnings per share basis. Rite Aid employs 48,000 workers across the globe.

What is Rite Aid's official website?

The official website for Rite Aid is www.riteaid.com.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.